Enzymatic vitreous disruption.

Enzymatic vitreous disruption.

Item
http://www.wikidata.org/entity/Q37091745
Ocriplasmin for symptomatic vitreomacular adhesionOcriplasmin: who is the best candidate?Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesionLong-Term Follow-Up of the Fellow Eye in Patients Undergoing Surgery on One Eye for Treating Myopic Traction Maculopathy.Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential.Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a reviewPharmacologic vitreolysis.Ocriplasmin for vitreoretinal diseases.Chondroitinase: A promising therapeutic enzyme.From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety.Ocriplasmin for symptomatic vitreomacular adhesion.Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature.Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids.Emerging pharmacotherapies for diabetic macular edema
P2860

Enzymatic vitreous disruption.

Item
http://www.wikidata.org/entity/Q37091745
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enzymatic vitreous disruption.
@en
Enzymatic vitreous disruption.
@nl
type
label
Enzymatic vitreous disruption.
@en
Enzymatic vitreous disruption.
@nl
prefLabel
Enzymatic vitreous disruption.
@en
Enzymatic vitreous disruption.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Enzymatic vitreous disruption.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698